Pesticide Exposure at a Mixing Plant
At 10:30, two workers at an agricultural chemical mixing plant are contaminated after a transfer hose fails. One is ambulatory but vomiting, salivating, and has pinpoint pupils; the other is collapsed near a 250-gallon tote labeled with a partial signal word and an EPA registration number. The spilled liquid is mixed with powder on a concrete pad; the outside temperature is 92°F with high humidity. The plant manager says the product is 'probably an organophosphate' but cannot find the SDS. The nearest hospital is 25 minutes away and has no hazmat decon room. The fire department has four Level A suits, two Level B suits, SCBA, and a decon trailer. The IC must decide PPE for entry, decon setup, and how to move the collapsed patient without spreading contamination.
1. What PPE should the IC select for the rescue entry and why?
Read the worked answer
Reasoning: The product is unknown but clinically consistent with an organophosphate: vomiting, salivation, and pinpoint pupils. Organophosphates are absorbed through skin, lungs, and eyes, so PPE must protect all routes. The collapsed patient is in the contaminated area, and the powder and liquid can become airborne.
- Use Level A with SCBA for the initial entry and rescue because the product and concentration are unknown and dermal absorption is likely. Level B with SCBA may be acceptable for outside support only if splashing is controlled, but it is not the first choice for entry into an unknown pesticide release.
- Do not use Level C: there is no cartridge selection basis and the atmosphere may be IDLH.
- Manage heat stress at 92°F: limit work time, use cooling and rehab, and rotate teams with medical monitoring.
- Use chemical-resistant gloves, boots, and taped seams; decon all entrants.
Balance: Level A is conservative but heat stress is a real hazard; the IC should shorten entry time rather than downgrade protection without monitoring and product data.
2. How should the IC set up decontamination and move the collapsed patient?
Read the worked answer
Reasoning: Decon must protect the hospital and EMS while not delaying critical care.
- Set up a technical decon corridor at the hot/warm boundary: gross removal, clothing removal and bagging, soap-and-water wash, rinse, and containment of runoff.
- Move the ambulatory patient first if they can assist; simultaneously prepare a backboard or roller system for the collapsed patient. Life safety takes priority, but decon should begin at the boundary before loading.
- Protect the airway and breathing; EMS should provide oxygen and consider atropine per protocol for organophosphate toxicity, while the IC ensures rescuer safety and decon.
- Bag clothing as evidence and to prevent secondary contamination; note the EPA registration number and partial label.
- Notify the receiving hospital of the suspected organophosphate exposure and the decon status.
- Contain runoff; do not let it enter storm drains.
Key: Decon is not optional, but it can be rapid and concurrent with medical stabilization.
3. The SDS is later found and identifies the product as malathion 50% liquid, not DOT-regulated. How does that change PPE and tactics?
Read the worked answer
Reasoning: A label of malathion 50% liquid changes the specific hazard but not the need for contamination control. Malathion is an organophosphate with lower volatility than many solvents, but the liquid and powder still present dermal and ingestion hazards, and the patient is symptomatic.
- Reassess PPE: Level B with SCBA may be adequate for outside operations once the product is confirmed and monitoring shows no IDLH atmosphere; Level A remains appropriate if there is visible mist, a confined space, or high concentration.
- Do not downgrade to Level C without air monitoring and cartridge selection; pesticide mixtures may contain solvents.
- Continue decon and medical treatment; symptoms drive care, not the label alone.
- Update the hospital and regulatory notifications if a reportable quantity was released.
Principle: Identification refines PPE and tactics, but symptomatic patients and unknown concentration keep the IC conservative.